Cargando…

Effects of Dietary Fat Intake on HDL Metabolism

High-density lipoprotein (HDL) is a lipoprotein which has anti-atherogenic property by reversing cholesterol transport from the peripheral tissues to liver. Low HDL-cholesterol (HDL-C) as well as high low-density lipoprotein-cholesterol (LDL-C) is associated with the development of coronary heart di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanai, Hidekatsu, Katsuyama, Hisayuki, Hamasaki, Hidetaka, Abe, Shinichi, Tada, Norio, Sako, Akahito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285059/ https://www.ncbi.nlm.nih.gov/pubmed/25584098 http://dx.doi.org/10.14740/jocmr2030w

Ejemplares similares

Effects of Carbohydrate and Dietary Fiber Intake, Glycemic Index and Glycemic Load on HDL Metabolism in Asian Populations
por: Yanai, Hidekatsu, et al.
Publicado: (2014)

Effects of Intake of Fish or Fish Oils on the Development of Diabetes
por: Yanai, Hidekatsu, et al.
Publicado: (2015)

Effects of 6-Month Sitagliptin Treatment on Metabolic Parameters in Diabetic Patients Taking Oral Glucocorticoids: A Retrospective Cohort Study
por: Katsuyama, Hisayuki, et al.
Publicado: (2015)

Associations between lower extremity muscle mass and metabolic parameters related to obesity in Japanese obese patients with type 2 diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2015)

Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2017)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters in Patients With Type 2 Diabetes: A Chart-Based Analysis
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering
por: Yanai, Hidekatsu, et al.
Publicado: (2016)

Correction: Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2015)

Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2015)

The Influences of Withdrawal and Daily Dose Reduction of Pioglitazone on Metabolic Parameters in Patients With Type 2 Diabetes: A Retrospective Longitudinal Observational Study
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

Hospitalization for Hypoglycemia in Japanese Diabetic Patients: A Retrospective Study Using a National Inpatient Database, 2008–2012
por: Sako, Akahito, et al.
Publicado: (2015)

Hospitalization with hypoglycemia in patients without diabetes mellitus: A retrospective study using a national inpatient database in Japan, 2008–2012
por: Sako, Akahito, et al.
Publicado: (2017)

Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline Data
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Habit of Bathing or Showering Is Beneficially Associated With Body Weight and Abdominal Circumference in Patients With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2018)

Daily Physical Activity Assessed by a Triaxial Accelerometer Is Beneficially Associated with Waist Circumference, Serum Triglycerides, and Insulin Resistance in Japanese Patients with Prediabetes or Untreated Early Type 2 Diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2015)

Exercise Therapy for Patients With Type 2 Diabetes: A Narrative Review
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

Which Nutritional Factors Are Good for HDL?
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

Habitual Hot-Tub Bathing and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Katsuyama, Hisayuki, et al.
Publicado: (2022)

Effects of 6-Month Sitagliptin Treatment on Glucose and Lipid Metabolism, Blood Pressure, Body Weight and Renal Function in Type 2 Diabetic Patients: A Chart-Based Analysis
por: Yanai, Hidekatsu, et al.
Publicado: (2012)

Streptococcal Infection Can Be the Trigger for Thyroid Storm
por: Hakoshima, Mariko, et al.
Publicado: (2019)

An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

An Influence of the Estimated Glomerular Filtration Rate on Improvement in Metabolic Parameters by Sodium-Glucose Cotransporter 2 Inhibitors
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Prescription of anti-influenza drugs in Japan, 2014–2020: A retrospective study using open data from the national claims database
por: Sako, Akahito, et al.
Publicado: (2023)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
por: Yanai, Hidekatsu, et al.
Publicado: (2021)

Hospitalization for urinary tract infections in Japan, 2010–2015: a retrospective study using a national inpatient database
por: Sako, Akahito, et al.
Publicado: (2021)

Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Clinical, Biochemical, Hematological, Endocrinological and Immunological Differences Between Graves’ Disease Patients With and Without Thyroid Storm
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

The Possible Mechanisms for Improvement of Liver Function due to Sodium-Glucose Cotransporter-2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

A Significant Increase of Estimated Glomerular Filtration Rate After Switching From Fenofibrate to Pemafibrate in Type 2 Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2021)

An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2021)

Serum Zn/Cu Ratio Is Associated with Renal Function, Glycemic Control, and Metabolic Parameters in Japanese Patients with and without Type 2 Diabetes: A Cross-sectional Study
por: Hamasaki, Hidetaka, et al.
Publicado: (2016)

A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia
por: Katsuyama, Hisayuki, et al.
Publicado: (2023)

A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

A Case of Insulin-Dependent Diabetes Associated With Enteroviral Infections
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)

Comment on: Tsiakou et al. Arterial Stiffness Is Inversely Related to Plasma Adiponectin Levels in Young Normotensive Patients With Type 1 Diabetes. Diabetes Care 2013;36:734–736
por: Hamasaki, Hidetaka, et al.
Publicado: (2013)

Handgrip strength is inversely associated with augmentation index in patients with type 2 diabetes
por: Hamasaki, Hidetaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sp2gq7pjgpavacmjgodu2cv2gr